keyword
https://read.qxmd.com/read/38648107/targeting-the-tgf-%C3%AE-signaling-pathway-an-updated-patent-review-2021-present
#1
REVIEW
Wenhao Guo, Hanwen Liu, Yong Yan, Di Wu, Hequan Yao, Kejiang Lin, Xuanyi Li
INTRODUCTION: The TGF-β signaling pathway is a complex network that plays a crucial role in regulating essential biological functions and is implicated in the onset and progression of multiple diseases. This review highlights the recent advancements in developing inhibitors targeting the TGF-β signaling pathway and their potential therapeutic applications in various diseases. AREA COVERED: The review discusses patents on active molecules related to the TGF-β signaling pathway, focusing on three strategies: TGF-β activity inhibition, blocking TGF-β receptor binding, and disruption of the signaling pathway using small molecule inhibitors...
April 22, 2024: Expert Opinion on Therapeutic Patents
https://read.qxmd.com/read/38647526/a-nanopore-sequencing-based-pharmacogenomic-panel-to-personalize-tuberculosis-drug-dosing
#2
JOURNAL ARTICLE
Renu Verma, Kesia Esther da Silva, Neesha Rockwood, Roeland E Wasmann, Nombuso Yende, Taeksun Song, Eugene Kim, Paolo Denti, Robert J Wilkinson, Jason R Andrews
RATIONALE: Standardized dosing of anti-tubercular (TB) drugs leads to variable plasma drug levels, which are associated with adverse drug reactions, delayed treatment response, and relapse. Mutations in genes affecting drug metabolism explain considerable interindividual pharmacokinetic variability; however, pharmacogenomic (PGx) assays that predict metabolism of anti-TB drugs have been lacking. OBJECTIVES: To develop a Nanopore sequencing panel and validate its performance in active TB patients to personalize treatment dosing...
March 5, 2024: American Journal of Respiratory and Critical Care Medicine
https://read.qxmd.com/read/38647433/practical-three-component-regioselective-synthesis-of-drug-like-3-aryl-or-heteroaryl-5-6-dihydrobenzo-h-cinnolines-as-potential-non-covalent-multi-targeting-inhibitors-to-combat-neurodegenerative-diseases
#3
JOURNAL ARTICLE
Hossein Mousavi, Mehdi Rimaz, Behzad Zeynizadeh
Neurodegenerative diseases (NDs) are one of the prominent health challenges facing contemporary society, and many efforts have been made to overcome and (or) control it. In this research paper, we described a practical one-pot two-step three-component reaction between 3,4-dihydronaphthalen-1(2 H )-one ( 1 ), aryl(or heteroaryl)glyoxal monohydrates ( 2a - h ), and hydrazine monohydrate (NH2 NH2 •H2 O) for the regioselective preparation of some 3-aryl(or heteroaryl)-5,6-dihydrobenzo[ h ]cinnoline derivatives ( 3a - h )...
April 22, 2024: ACS Chemical Neuroscience
https://read.qxmd.com/read/38647399/hybrid-membrane-coated-nanoparticles-for-precise-targeting-and-synergistic-therapy-in-alzheimer-s-disease
#4
JOURNAL ARTICLE
Rong-Rong Lin, Lu-Lu Jin, Yan-Yan Xue, Zhe-Sheng Zhang, Hui-Feng Huang, Dian-Fu Chen, Qian Liu, Zheng-Wei Mao, Zhi-Ying Wu, Qing-Qing Tao
The blood brain barrier (BBB) limits the application of most therapeutic drugs for neurological diseases (NDs). Hybrid cell membrane-coated nanoparticles derived from different cell types can mimic the surface properties and functionalities of the source cells, further enhancing their targeting precision and therapeutic efficacy. Neuroinflammation has been increasingly recognized as a critical factor in the pathogenesis of various NDs, especially Alzheimer's disease (AD). In this study, a novel cell membrane coating is designed by hybridizing the membrane from platelets and chemokine (C-C motif) receptor 2 (CCR2) cells are overexpressed to cross the BBB and target neuroinflammatory lesions...
April 22, 2024: Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
https://read.qxmd.com/read/38646934/pyrimidine-depletion-enhances-targeted-and-immune-therapy-combinations-in-acute-myeloid-leukemia
#5
JOURNAL ARTICLE
Ola A Elgamal, Sydney Fobare, Sandip Vibhute, Abeera Mehmood, Dennis C Vroom, Mariah L Johnson, Blaise Stearns, James R Lerma, Jean Truxall, Emily Stahl, Bridget Carmichael, Shelley J Orwick, Alice S Mims, Emily Curran, Ramasamy Santhanam, Susheela Tridandapani, Mitch A Phelps, Zhiliang Xie, Christopher C Coss, Sharyn D Baker, Jeffrey Patrick, Janel K Ezzell, Jayesh Rai, Jianmin Pan, Shesh N Rai, Cody Stillwell, Mark Wunderlich, Mouad Abdulrahim, Thomas E Goodwin, Gerard Hilinski, Chad E Bennett, Erin Hertlein, John C Byrd
Acute myeloid leukemia (AML) is a fatal disease characterized by the accumulation of undifferentiated myeloblasts, and agents that promote differentiation have been effective in this disease but are not curative. Dihydroorotate dehydrogenase inhibitors (DHODHi) have the ability to promote AML differentiation and target aberrant malignant myelopoiesis. We introduce HOSU-53, a DHODHi with significant monotherapy activity, which is further enhanced when combined with other standard-of-care therapeutics. We further discovered that DHODHi modulated surface expression of CD38 and CD47, prompting the evaluation of HOSU-53 combined with anti-CD38 and anti-CD47 therapies, where we identified a compelling curative potential in an aggressive AML model with CD47 targeting...
April 22, 2024: JCI Insight
https://read.qxmd.com/read/38646906/design-and-synthesis-of-mandelic-acid-derivatives-for-suppression-of-virulence-via-t3ss-against-citrus-canker
#6
JOURNAL ARTICLE
Yu-Qing Zhang, Xin Wang, Huabin Shi, Faisal Siddique, Jiaxin Xian, Aiting Song, Boli Wang, Zhibing Wu, Zi-Ning Cui
Citrus canker, a highly contagious bacterial disease caused by Xanthomonas citri subsp. citri ( Xcc ), poses a substantial threat to citrus crops, leading to serious reductions in fruit yield and economic losses. Most commonly used bactericides against Xcc lead to the rapid development of resistant subpopulations. Therefore, it is imperative to create novel drugs, such as type III secretion system (T3SS) inhibitors, that specifically target bacterial virulence factors rather than bacterial viability. In our study, we designed and synthesized a series of mandelic acid derivatives including 2-mercapto-1,3,4-thiazole...
April 22, 2024: Journal of Agricultural and Food Chemistry
https://read.qxmd.com/read/38646905/pharmacotherapy-considerations-for-patients-who-develop-acute-kidney-injury-during-cancer-therapy
#7
REVIEW
Emanuele Parodi, Maura Rossi, Achille Bottiglieri, Marco Ladetto, Guido Merlotti, Vincenzo Cantaluppi, Marco Quaglia
INTRODUCTION: Acute kidney injury (AKI) frequently develops in patients receiving cancer therapy and requires a wide differential diagnosis due to possible role of unique cancer and drug-related factors, in addition to common pre- and post-renal causes. Rapid development of new molecular targeted anti-cancer drugs and immunotherapies has opened unprecedented possibilities of treatment at the price of an increased spectrum of renal side effects. AREAS COVERED: The present review aims at providing a state-of-the-art picture of AKI in cancer patient (PubMed and Embase libraries were searched from inception to January 2024), with a focus on differential diagnosis and management of diverse clinical settings...
April 22, 2024: Expert Opinion on Pharmacotherapy
https://read.qxmd.com/read/38646688/the-clinical-and-immunological-features-of-alopecia-areata-following-sars-cov-2-infection-or-covid-19-vaccines
#8
REVIEW
Shiqi Fu, Xiuzu Song
INTRODUCTION: Alopecia areata (AA) is an autoimmune disease induced by viral infection or vaccination. With the increased incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the incidence of AA has also increased. Recently the incidence was found to be 7.8% from a previously reported rate of 2.1%. The physical and psychological damage caused by AA could seriously affect patients' lives, while AA is a challenging dermatological disease owing to its complex pathogenesis...
April 22, 2024: Expert Opinion on Therapeutic Targets
https://read.qxmd.com/read/38646682/a-review-on-tau-targeting-biomimetics-nano-formulations-novel-approach-for-targeting-alzheimer-s-diseases
#9
JOURNAL ARTICLE
Aditya Singh, Shubhrat Maheshwari, Jagat Pal Yadav, Aditya Prakash Varshney, Sudarshan Singh, Bhupendra G Prajapati
Central nervous system disorders are prevalent, profoundly debilitating, and poorly managed. Developing innovative treatments for these conditions, including Alzheimer's disease, could significantly improve patients' quality of life and reduce the future economic burden on healthcare systems. However, groundbreaking drugs for central nervous system disorders have been scarce in recent years, highlighting the pressing need for advancements in this field. One significant challenge in the realm of nanotherapeutics is ensuring the precise delivery of drugs to their intended targets due to the complex nature of Alzheimer's disease...
March 25, 2024: Central Nervous System Agents in Medicinal Chemistry
https://read.qxmd.com/read/38646497/the-numerous-facets-of-1q21-in-multiple-myeloma-pathogenesis-clinicopathological-features-prognosis-and-clinical-progress-review
#10
REVIEW
Na Liu, Zhanzhi Xie, Hao Li, Luqun Wang
Multiple myeloma (MM) is a malignant neoplasm characterized by the clonal proliferation of abnormal plasma cells (PCs) in the bone marrow and recurrent cytogenetic abnormalities. The incidence of MM worldwide is on the rise. 1q21+ has been found in ~30-40% of newly diagnosed MM (NDMM) patients.1q21+ is associated with the pathophysiological mechanisms of disease progression and drug resistance in MM. In the present review, the pathogenesis and clinicopathological features of MM patients with 1q21+ were studied, the key data of 1q21+ on the prognosis of MM patients were summarized, and the clinical treatment significance of MM patients with 1q21+ was clarified, in order to provide reference for clinicians to develop treatment strategies targeting 1q21+ ...
June 2024: Oncology Letters
https://read.qxmd.com/read/38646493/non%C3%A2-coding-rna-a-promising-diagnostic-biomarker-and-therapeutic-target-for-esophageal-squamous-cell-carcinoma-review
#11
REVIEW
Longze Zhang, Yanyang Wang, Jianmei Gao, Xue Zhou, Minglei Huang, Xianyao Wang, Zhixu He
Esophageal cancer (EC) is a common form of malignant tumor in the digestive system that is classified into two types: Esophageal squamous cell carcinomas (ESCC) and esophageal adenocarcinoma. ESCC is known for its early onset of symptoms, which can be difficult to identify, as well as its rapid progression and tendency to develop drug resistance to chemotherapy and radiotherapy. These factors contribute to the high incidence of disease and low cure rate. Therefore, a diagnostic biomarker and therapeutic target need to be identified for ESCC...
June 2024: Oncology Letters
https://read.qxmd.com/read/38646426/targeting-estrogen-mediated-cyp4f2-cyp4f11-20-hete-metabolic-disorder-decelerates-tumorigenesis-in-er-breast-cancer
#12
JOURNAL ARTICLE
Juan Yang, Yin Li, Xiao Han, Tianjiao Li, Ding Li, Qiao Liu, Lizhong Yan, Fei Li, Xiaolin Pei, Ya Feng, Zhoujun Lin, Zhenkun Fu, Changjun Wang, Qiang Sun, Chenggang Li
PURPOSE: As the most common subset of breast cancer (BC), estrogen receptor positive (ER+) BC accounting for 80% of cases, has become a global public health concern. The female hormone estrogen (E2) unequivocally drives ER + breast malignancies. The reasons that estrogen affects BC development has long been considered, yet further study remains to be conducted of the molecular events in the E2-estrogen receptor α (ERα) signaling pathway in ER + BC progression, especially lipid metabolism, so providing more options for tailored and individualized therapy...
July 2024: Biochemistry and Biophysics Reports
https://read.qxmd.com/read/38646170/-mycobacterial-sapm-hampers-host-autophagy-initiation-for-intracellular-bacillary-survival-via-dephosphorylating-raptor
#13
JOURNAL ARTICLE
Wei Zhang, Chunsheng Dong, Sidong Xiong
Secreted acid phosphatase (SapM) is an immunomodulator of Mycobacterium tuberculosis (Mtb) and consequently plays a crucial role in disease onset and development upon infection. Importantly, the virulence of SapM has rendered SapM an attractive target for drug development. However, the mechanism underlying the role of SapM in facilitating bacillary survival remains to be fully elucidated. In this context, the present study demonstrated that SapM hampered cellular autophagy to facilitate bacillary survival in  mycobacterial -infected macrophages...
May 17, 2024: IScience
https://read.qxmd.com/read/38645989/network-pharmacology-and-molecular-docking-identify-the-potential-mechanism-and-therapeutic-role-of-scutellaria-baicalensis-in-alzheimer-s-disease
#14
JOURNAL ARTICLE
Yutao Peng, Chanjuan Zhou
AIM: Scutellaria baicalensis , a traditional Chinese medicinal herb renowned for its anti-inflammatory, antioxidant, and anti-tumor properties, has shown promise in alleviating cognitive impairment associated with Alzheimer's disease. Nonetheless, the exact neuroprotective mechanism of Scutellaria baicalensis against Alzheimer's disease remains unclear. In this study, network pharmacology was employed to explore the possible mechanisms by which Scutellaria baicalensis protects against Alzheimer's disease...
2024: Drug Design, Development and Therapy
https://read.qxmd.com/read/38645986/a-novel-network-pharmacology-strategy-based-on-the-universal-effectiveness-common-mechanism-of-medical-herbs-uncovers-therapeutic-targets-in-traumatic-brain-injury
#15
JOURNAL ARTICLE
Zhe Yu, Ruoqi Ding, Qiuju Yan, Menghan Cheng, Teng Li, Fei Zheng, Lin Zhu, Yang Wang, Tao Tang, En Hu
PURPOSE: Many herbs can promote neurological recovery following traumatic brain injury (TBI). There must lie a shared mechanism behind the common effectiveness. We aimed to explore the key therapeutic targets for TBI based on the common effectiveness of the medicinal plants. MATERIAL AND METHODS: The TBI-effective herbs were retrieved from the literature as imputes of network pharmacology. Then, the active ingredients in at least two herbs were screened out as common components...
2024: Drug Design, Development and Therapy
https://read.qxmd.com/read/38645649/mapping-the-flow-of-veterinary-antibiotics-in-kenya
#16
JOURNAL ARTICLE
Alexina K Morang'a, Dishon M Muloi, Simon M Kamau, Joshua O Onono, Peter B Gathura, Arshnee Moodley
INTRODUCTION: To effectively regulate and reduce antibiotic use, in the livestock sector, a thorough understanding of the flow of veterinary antibiotics will help to identify key nodes in the chain for targeted interventions. The aim of this study was to understand the flow of antibiotics from import to end-user, and identify relevant governance mechanisms. METHODS: A mixed methods approach was used to collect data in three Kenyan counties (Nairobi, Kiambu, and Kajiado)...
2024: Frontiers in Veterinary Science
https://read.qxmd.com/read/38645585/a-review-of-functional-neuromodulation-in-humans-using-low-intensity-transcranial-focused-ultrasound
#17
REVIEW
Kyuheon Lee, Tae Young Park, Wonhye Lee, Hyungmin Kim
Transcranial ultrasonic neuromodulation is a rapidly burgeoning field where low-intensity transcranial focused ultrasound (tFUS), with exquisite spatial resolution and deep tissue penetration, is used to non-invasively activate or suppress neural activity in specific brain regions. Over the past decade, there has been a rapid increase of tFUS neuromodulation studies in healthy humans and subjects with central nervous system (CNS) disease conditions, including a recent surge of clinical investigations in patients...
May 2024: Biomedical Engineering Letters
https://read.qxmd.com/read/38645562/use-of-bailing-capsules-cordyceps-sinensis-in-the-treatment-of-chronic-kidney-disease-a-meta-analysis-and-network-pharmacology
#18
REVIEW
Yilin Tao, Ruixiang Luo, Yuanbing Xiang, Min Lei, Xuan Peng, Yao Hu
The Bailing Capsule is a commonly used traditional Chinese medicine for the treatment of chronic kidney disease (CKD). However, its therapeutic effects and pharmacological mechanisms have not been fully explored. In this study, we integrated meta-analysis and network pharmacology to provide scientific evidence for the efficacy and pharmacological mechanism of Bailing Capsule in treating CKD. We conducted searches for randomized controlled studies matching the topic in PubMed, the Cochrane Library, Embase, Web of Science, and the Wanfang Database, and screened them according to predefined inclusion and exclusion criteria...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38645513/the-emerging-therapies-are-reshaping-the-first-line-treatment-for-advanced-hepatocellular-carcinoma-a-systematic-review-and-network-meta-analysis
#19
JOURNAL ARTICLE
Wei Peng, Yangxun Pan, Lan Xie, Zhoutian Yang, Zhiwei Ye, Jinbin Chen, Juncheng Wang, Dandan Hu, Li Xu, Zhongguo Zhou, Minshan Chen, Aiping Fang, Yaojun Zhang
BACKGROUND: Given the superior performance of various therapies over sorafenib in advanced hepatocellular carcinoma (HCC) and the absence of direct comparisons, it is crucial to explore the efficacy of these treatments in phase III randomized clinical trials. OBJECTIVES: The goal is to identify which patients are most likely to benefit significantly from these emerging therapies, contributing to more personalized and informed clinical decision-making. DESIGN: Systematic review and network meta-analysis...
2024: Therapeutic Advances in Gastroenterology
https://read.qxmd.com/read/38645427/endothelial-dysfunction-in-vascular-complications-of-diabetes-a-comprehensive-review-of-mechanisms-and-implications
#20
REVIEW
Dong-Rong Yang, Meng-Yan Wang, Cheng-Lin Zhang, Yu Wang
Diabetic vascular complications are prevalent and severe among diabetic patients, profoundly affecting both their quality of life and long-term prospects. These complications can be classified into macrovascular and microvascular complications. Under the impact of risk factors such as elevated blood glucose, blood pressure, and cholesterol lipids, the vascular endothelium undergoes endothelial dysfunction, characterized by increased inflammation and oxidative stress, decreased NO biosynthesis, endothelial-mesenchymal transition, senescence, and even cell death...
2024: Frontiers in Endocrinology
keyword
keyword
169911
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.